CAS: 5514-81-8

Betamethasone 21-acetate-17-propionate is a drug product that is a mixture of betamethasone and betamethasone dipropionate. It is used to treat inflammatory skin conditions such as dermatitis, eczema, psoriasis, and other conditions. Betamethasone 21-acetate-17-propionate is one of the most potent corticosteroids available for topical use. The validation process has been completed on the acetonitrile phase and the reversed phase mobile phase. The validation was successful for both the acetonitrile and reversed phases. A validated HPLC method was developed for this drug product in order to monitor its production process.

Impurity Betamethasone Dipropionate EP Impurity D Applications Betamethasone 21-acetate-17-propionate (Betamethasone Dipropionate EP Impurity D) is a related compound of Betamethasone dipropionate (B327005). References Grootveld, M., et al.: Biochem. Pharmacol., 37, 271 (1988), Chen, B., et al.: Steriods, 74, 30 (2009), Mikami, E., et al.: J. Pharm. Biomed. Anal., 28, 261 (2002),

Applications Labelled Betamethasone 21-acetate-17-propionate (B327040). Betamethasone 21-acetate-17-propionate is a related compound of Betamethasone dipropionate (B327005). References Grootveld, M., et al.: Biochem. Pharmacol., 37, 271 (1988), Chen, B., et al.: Steriods, 74, 30 (2009), Mikami, E., et al.: J. Pharm. Biomed. Anal., 28, 261 (2002),